Peptide Price Finder

Home · Clinical trials

Testagen clinical trials

ClinicalTrials.gov lists 1 registered trial of Testagen: 1 recruiting or about to, 0 running, 0 completed. The largest is Product Transference Study of Testagen™ TDS®-Testosterone (96 people).

1registered trials

1recruiting now

0running

0completed

0in phase 3

0with results posted

Recruiting: 11trials
  • Recruiting 1

Where Testagen is in testing

Registered trials by phase. Phase 3 trials are the large ones that decide approval.

0Early phase 1First doses in people
0Phase 1Safety and dosing
1Phase 2Does it work?
0Phase 3Large confirmatory trials
0Phase 4After approval
0Not phasedObservational and other

Timeline

Each bar runs from a trial's start to its planned end; faded bars have no end date. Click a bar to open the trial.

20272028Product Transference Study of Testagen™ TDS®-Testosterone · Recruiting · Phase 2 · 96 people · 2027-01-05 to 2027-10
RecruitingRunningCompletedStopped or withdrawnStatus unknownToday

Where trials are recruiting

Countries with sites in trials that are recruiting now.

Recruiting now 1

Product Transference Study of Testagen™ TDS®-Testosterone

Not yet recruitingPhase 296 peopleRandomizedTransdermal Delivery Solutions Corp2027-01-05 → 2027-10

Studying: Hypogonadotropism · NCT02733133

About this trial

This study will assess the potential of Testagen® TDS-Testosterone to enable transfer of Testosterone to females coming in contact with skin to which Testagen® TDS-Testosterone has been applied and the potential of product to raise serum androgen levels in those women.

Registered trials include ones that haven't published results yet. Trials are matched on the compound's name and code names (Testagen) in the listed interventions.